BioSpace News Archive

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced that they will co-host the first Duchenne Muscular Dystrophy Platform Trial Community Meeting, along with collaborators I-ACT for Children and Critical Path Institute (C-Path) on September 9, 2019 at the Sheraton Silver Spring in Silver Spring, Maryland.

Landrace Bioscience, an industrial-scale hemp processor, recently confirmed a team of experts to its advisory board.

Interpreta, Inc., an analytics company that intelligently synchronizes healthcare to improve quality, has been selected by the National Committee for Quality Assurance (NCQA) to be a beta vendor for the third consecutive year for the Healthcare Effectiveness Data and Information Set (HEDIS®) 2020, and Integrated Healthcare Association’s (IHA) Align. Measure. Perform (AMP) Measure Certification season.

Today the Wyss Institute for Biologically Inspired Engineering at Harvard University announced that its athlete microbiome-based technology will be commercialized by Fitbiomics Inc., a recently formed startup company, to develop highly validated probiotics based on elite athletes’ microbiomes, which could improve athletic performance and, conceivably, even overall health.

Nichi-Iko Pharmaceutical Co., Ltd. (“Nichi-Iko”) and Sagent Pharmaceuticals, Inc., a Nichi-Iko Group Company (“Sagent”), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that their Canadian subsidiary, Omega Laboratories Limited (“Omega”), has been found acceptable for manufacturing FDA-approved products in its initial Establishment Inspection Report issued by the U.S. FDA.

CHA Hollywood Presbyterian Medical Center (CHA HPMC), a hospital that is a member of CHA Health Systems, a global network providing a full spectrum of dynamic healthcare services, announces that Rohit Varma, MD, MPH, director of its Southern California Eye Institute (SCEI), has performed the first ClearPath implant surgery in Los Angeles, on a 78-year-old glaucoma patient.

Clinical genomic testing and next-generation sequencing (NGS) are integral parts of realizing the potential of precision medicine, but the data complexity and technical integrations needed to make genomic data clinically meaningful and routinized have slowed mainstream adoption of these breakthrough technologies

On the heels of Chat Translate, Medici introduces Chat Collaboration to enable providers to add colleagues to telemedicine consults with patients on the Medici platform

Surgical Innovation Associates (SIA), an early-stage medical device company, announced today the first use of its DuraSorb® Monofilament Mesh by Chicago plastic surgeon Karol Gutowski, MD, FACS, past president of the Illinois Society of Plastic Surgeons and clinical affiliate of both University of Chicago and University of Illinois

The Alzheimer’s Research and Prevention Foundation (ARPF) will host its third Brain Longevity Therapy Training and Symposium on October 24-27 in Scottsdale, AZ.